Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is sketchy when last trade was .184 but a big block pops up at .182 for a min then it went away somthing is def brewing up
A little volatile but descent volume comin in
Nice gap up only 17k left At .185
my phone died i missed power hour
VERY BULLISH CLOSE I SEE!!!
lets see what pops off tomorrow i bet we gap up above .18 instantly at open
JMHO!
Hahhhhhh yea I figured I got nothing to hide big investor could mean 1 thousand or millions depends on investor to slime 500 shares is alot
Tick rock tick down to .0001 srge scam of the century goes. TICK toCk tob tick tock
Same boards for everyone
IMO this is as far as we should have fell after financials the rest was pure mm manipulation to steal cheapies
I don't have l2. Etrade has accurate up to date bid ask I just get it 15 min before it son ihub I'm sure many others have the same l2 is bullshit u gotta pay out the a for it
54 k at .173
No volume no news no green
.175 ASK we have shaken weak hands/profit takers ask is creeping up get ready fro next leg up
THE POP HAS ALREADY BEGUN MY FRIENDS
THE SHORTS CAN CONTINUE TO KICK THE CAN & HOPE FOR BETTER LUCK NEXT TIME
I FOR 1 AM GLAD I TOOK A LARGE LONG POSITION IN MARCH 2009 AT .16 PER SHARE AND HAVE NOT EVEN THOUGHT ABOUT SELLING ANY!
MUST BE HARD CONSTANTLY SHORTING SIRIUS AND GETTING THE SHORT END OF THE STICK OVER AND OVER AGAIN
KEEP TRYING TO HOLD DOWN THIS BEAST IT WILL NOT HAPPEN
no news no volume i searched all over the internet searching for the pps increase
so with no volume and no newshere we satnd
we need some news or some big buys to continue move until then we will sit here or even drop back down more slowly
WE NEED SOMETHING!
spoke to soon it is being held down here
significant volume is needed to break through .17 resistance
we should be able to push though the 80k ask at .17 with a few nice slaps in power hr
NOT A CHANCE
another gap up is nice to wake up to
This comment follows, which was nice to see
opeters
0 Fans
12:10 PM on 02/13/2013
While there are many solutions being evaluated, Applied DNA Sciences' digitalDNA(R) is perhaps the most advance anti-counterfeiting, trace and traceable system being considered, among other attributes it is compliant with the current California's e-pedigree law being considered for national roll-out.
According to their site...The combined DNA-IT platform will also aim to satisfy requirements of the California E-Pedigree Law (SB 1307 (Ridley-Thomas, Chapter 713, Statutes of 2008), which requires an electronic record of every sale of prescription drugs in the state. The pedigree must thoroughly document the drug, including its source, identification, and other data. Some features of the law require compliance as early as 2015. The California law is said by many to have wide repercussions for the pharmaceutical industry globally.
ROME WASN'T BUILT IN A DAY
i am a small time investor
but i do follow the market daily and religiously follow my holdings like a hawk
just look over the last year at any of the times the there was over 5mil in volume like today and look the pps reacted i would say we are good for the time being
yes i was very very close to cutting my losses, as many investors surely did .. But i could not keep my eye off of apdn, and i bought 4 different times over the last week and im very happy i did!
Im glad the small bunch of dedicated long believers on these boards are going to reap the benefits. It was hard to watch but the stock market is not for the weak.
great dd and confidence cannot be taught.
HELLO FULL FILLED GREEN CANDLE CARRYING 10 MILLION VOLUME...WOW
That was all short stealing shares!!! Congrats to those who held
Apdn celebrating green for st patty
patience is a virtue !!!!!!
looks like the GREAT WALL has been plowed over !
Look for more and more "smart money" checking out these charts and looking deeper into apdn .
There is much too much opportunity for us to fail
Patients s a Virtue and APDN will prevail!!!!
People are getting bored I can see why . Wall has been beefed up to 220k
Tob I give u credit u try very hard but the party is over!!! .0001 weeeeeeeeeee
How will they pay tons Salary ! We have an epidemic people have completely stopped believing . What will we do now!
200k wall at .13
Siri has traded on the Nasdaq for years under 4$ a shares
didnt mean to reply to your post directly but as always great dd and it is much appreciated
please explain why anyone would rush to throw 76 k on the bid at .1285 when an hr ago they were selling over .13
IMHO I was wrong the shorts have not loosened their grip they are still toying with poor apdn
these chart look ready and set for a huge full filled candle green pop in the coming days
CytoSorbents to Exhibit at the ISICEM 2013 Critical Care Conference
Mar 13, 2013 08:15:00 (ET)
MONMOUTH JUNCTION, N.J., March 13, 2013 /PRNewswire via COMTEX/ -- CytoSorbents Corporation , a critical care focused company using blood purification to treat life-threatening illnesses, announced that it will exhibit its European Union approved CytoSorb® cytokine reduction technology at the 33rd International Symposium on Intensive Care and Emergency Medicine (ISICEM) in Brussels, Belgium from March 19-22, 2013. In addition, Dr. Dirk Schadler, from the University Hospital, Universitatsklinikum Schleswig-Holstein, at Kiel University, Kiel, Germany, was selected to present a poster (#P062) at the conference entitled, "A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients." Finally, CytoSorbents will also host an evening that will bring together current and potential customers to talk about critical care medicine and to share real world experiences using CytoSorb®.
Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, stated, "We are pleased at the growing recognition and usage of CytoSorb® by leading experts in the field of critical care medicine in many different applications. We have already seen exciting cases in such areas as sepsis, burn injury, trauma, lung injury, cardiac surgery, liver failure, pancreatitis, influenza, and other indications. Users have confirmed the simplicity and ease of use of the CytoSorb® therapy. As we expand our commercialization efforts, we look forward to beginning a number of investigator-initiated studies this year in many different areas that may help drive future adoption and awareness for our technologies."
About ISICEMThe International Symposium on Intensive Care and Emergency Medicine is organized by the Departments of Intensive Care and Emergency Medicine of Erasme University Hospital, Universite Libre de Bruxelles, in association with the Belgian Society of Intensive Care and Emergency Medicine. This annual conference was started in 1980 and has become established as one of the largest in its field, now attracting more than 6,000 participants from countries worldwide. The objectives of this four-day symposium are to provide participants with an up-to-date review of the most recent, clinically relevant, developments in research, therapy, and management of the critically ill. The meeting is open to all physicians, nurses, and other health professionals with an interest in critical care or emergency medicine.
About CytoSorbents CorporationCytoSorbents Corporation is a critical care focused therapeutic device company using blood purification to treat life-threatening illnesses commonly seen in the intensive care unit such as sepsis and infection, influenza, severe lung injury, trauma, burn injury, and pancreatitis. Its purification technology is based upon biocompatible, highly porous polymer beads that can efficiently remove toxic substances from blood and other bodily fluids. The Company's flagship product CytoSorb®, a first-in-class extracorporeal cytokine filter compatible with standard hemodialysis machines, has achieved European Union CE Mark regulatory approval and is now being commercialized in Europe. The goal of the CytoSorb® cytokine filter is to prevent or treat multiple organ failure, the leading cause of death in the intensive care unit, by reducing the excessive production of cytokines, or "cytokine storm", that could otherwise lead to deadly inflammation, organ injury, and death. Organ failure represents one of the most serious unmet medical needs in modern medicine, claiming millions of lives around the world, at a cost of tens of billions of dollars, each year. By actively addressing one of the most important underlying causes of organ failure, CytoSorb® represents a potentially revolutionary advance in the treatment of critical illnesses.
CytoSorbents has been awarded $5 million in contracts from both DARPA and the US Army, and continues to invest significantly in its research and development pipeline. One of its most advanced products under development is HemoDefend, a blood purification technology platform for the blood transfusion industry intended to reduce transfusion reactions and improve the safety of "old" blood by removing many substances, such as antibodies, free hemoglobin and inflammatory mediators that can cause potentially serious and sometimes fatal transfusion reactions.
CytoSorb® and HemoDefend are just two of a number of different polymers the Company has developed for various medical applications, including improved dialysis, reduction of post-surgical complications in cardiac surgery, treatment of inflammatory and autoimmune disorders, radio-imaging contrast removal in imaging and interventional radiology procedures, and the treatment of rhabdomyolysis, drug overdose, and others. Additional information is available for download on the Company's website: http://www.cytosorbents.com .
Forward-Looking Statements This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release are not promises or guarantees and are subject to risks and uncertainties that could cause our actual results to differ materially from those anticipated. These statements are based on management's current expectations and assumptions and are naturally subject to uncertainty and changes in circumstances. We caution you not to place undue reliance upon any such forward-looking statements. Actual results may differ materially from those expressed or implied by the statements herein. CytoSorbents Corporation and CytoSorbents, Inc believe that its primary risk factors include, but are not limited to: obtaining government approvals including required FDA and additional CE Mark approvals; ability to successfully develop commercial operations; dependence on key personnel; acceptance of the Company's medical devices in the marketplace; the outcome of potential litigation; compliance with governmental regulations; reliance on research and testing facilities of various universities and institutions; the ability to obtain adequate and timely financing in the future when needed; product liability risks; limited manufacturing experience; limited marketing, sales and distribution experience; market acceptance of the Company's products; competition; unexpected changes in technologies and technological advances; and other factors detailed in the Company's Form 10-K filed with the SEC on March 31, 2012, which is available at http://www.sec.gov .
Company Contact:CytoSorbents CorporationDr. Phillip Chan Chief Executive Officer (732) 329-8885 ext. *823 pchan@cytosorbents.com
Investor Contact:Alliance Advisors, LLCAlan Sheinwald(914) 669-0222asheinwald@allianceadvisors.net
Valter Pinto(914) 669-0222 x201valter@allianceadvisors.net
SOURCE CytoSorbents Corporation
130k on the bid at .132
Silence from chan a d the clan as far as what is really goin on behind the scenes. What's the real deal chan lets at least have a pr with some kind of real answers not just beating around the bush and playing dumb. Lets here it already what's the deal
All i see is the 100k orders going through closer to .14 than to .12. so big money is confident at around .14 shows a sign of strength IMHO